March 09, 2021
Feature Articles
30
3
Understanding the role of social determinants on clinical trial participation and trust.
March 09, 2021
Peer Reviewed
30
3
Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.
March 09, 2021
Feature Articles
30
3
New technological solutions for both patients and HCPs create a well-rounded eClinical approach
March 09, 2021
Feature Articles
30
3
Push for accurate data collection during pandemic led by increased focus on patient engagement.
March 09, 2021
Q&A
30
3
In this interview, Heather Kopetskie, Director of Biostatistics for Rho, discusses some points related to proactively managing the many “e”s in data collection.
March 09, 2021
Issue PDF
30
3
Click the title above for a link to open the Applied Clinical Trials March 2021 issue in an interactive PDF format.
March 09, 2021
From the Editor
30
3
Applying a year's worth of lessons to next generation clinical trials.
March 09, 2021
Feature Articles
30
3
eClinical, eSource and EHRs is the journey to the holy grail of data efficiency in clinical trials.
March 09, 2021
Q&A
30
3
Shiri Diskin, PhD, Head of Medical Writing at Bioforum, sits down with Daphna Laifenfeld, PhD, Chief Scientific Officer at Ibex Medical Analytics to discuss the challenges associated with developing a CER and how to effectively navigate them while creating opportunities that increase efficiencies.
March 01, 2021
View from Washington
30
3
Vaccine manufacturers anticipate significant boosts in output in the coming weeks.
February 25, 2021
View from Brussels
30
3
The latest initiative against COVID, the European Health Emergency Preparedness and Response Authority, is taking shape with intentions of revealing the vulnerabilities in global supply chains and more.
February 24, 2021
A Closing Thought
30
3
A top-down analysis of the decentralized trial model’s benefits and impact on the industry.
February 16, 2021
View from Brussels
30
3
After three years, member states of the EU have yet to make any real progress on legislation that would coordinate their clinical assessments more closely.
February 12, 2021
View from Washington
30
3
R&D on medical treatments lags notable success with vaccines.